Luigiano Carmelo, Ferrara Francesco, Fabbri Carlo, Ghersi Stefania, Bassi Marco, Billi Paola, Polifemo Anna Maria, Landi Patrizia, Cennamo Vincenzo, Consolo Pierluigi, Morace Carmela, Alibrandi Angela, D'Imperio Nicola
Unit of Gastroenterology and Digestive Endoscopy, AUSL Bologna Bellaria-Maggiore Hospital, Bologna, Italy.
Scand J Gastroenterol. 2011 May;46(5):591-6. doi: 10.3109/00365521.2011.551886. Epub 2011 Jan 27.
The aim of this study was to evaluate the outcomes of through-the-scope (TTS) large diameter self-expanding metal stent (SEMS) placement for palliation of malignant colorectal obstruction.
Between January 2005 and December 2009, all patients who underwent endoscopic SEMS placement for palliation of malignant colorectal obstruction were prospectively enrolled.
Thirty-nine patients (17M and 22F; mean age 75.9 ± 10.6 years, range 50-91) were enrolled. The most frequent location was the sigmoid colon (13 cases). The causes of obstruction were colorectal malignancy in 32 patients and extracolonic malignancy in 7. Technical success was achieved in 36/39 patients (92.3%) and clinical success in 35/39 patients (89.7%). Technical failure was related to female sex (p = 0.04) and the extracolonic etiology of the stricture (p < 0.001). There were three early complications: two procedure-related perforations successfully managed conservatively and one hemorrhage treated with APC. Early complications were related to the location of strictures at the recto-sigmoid junction (p < 0.001). Late complications occurred in 10 patients: 8 of these patients experienced occlusive symptoms (attributable to tumor ingrowth in 5 cases and stool impaction in 3 cases); the remaining 2 were one case of tumor ingrowth with sub-occlusive symptoms and hemorrhage, and one case of distal migration. There was no procedure-related mortality and all complications were managed without surgical intervention. SEMS patency duration was 236 ± 128 days (range 31-497) and mean survival of the patients was 259 ± 121 days (range, 32-511).
In our experience, TTS large-diameter SEMS placement is a safe and effective treatment for palliation of malignant colorectal obstruction.
本研究旨在评估经内镜大直径自膨式金属支架(SEMS)置入术缓解恶性大肠梗阻的疗效。
2005年1月至2009年12月,前瞻性纳入所有因恶性大肠梗阻接受内镜下SEMS置入术的患者。
共纳入39例患者(男性17例,女性22例;平均年龄75.9±10.6岁,范围50 - 91岁)。最常见的梗阻部位是乙状结肠(13例)。梗阻原因:32例为大肠恶性肿瘤,7例为结肠外恶性肿瘤。36/39例患者(92.3%)技术成功,35/39例患者(89.7%)临床成功。技术失败与女性性别(p = 0.04)及狭窄的结肠外病因(p < 0.001)有关。有3例早期并发症:2例与操作相关的穿孔经保守治疗成功处理,1例出血经氩离子凝固术治疗。早期并发症与直肠乙状结肠交界处狭窄的位置有关(p < 0.001)。10例患者发生晚期并发症:其中8例出现梗阻症状(5例因肿瘤长入,3例因粪便嵌塞);其余2例,1例为肿瘤长入伴亚梗阻症状及出血,1例为远端移位。无手术相关死亡,所有并发症均未行手术干预。SEMS通畅持续时间为236±128天(范围31 - 497天),患者平均生存期为259±121天(范围32 - 511天)。
根据我们的经验,经内镜大直径SEMS置入术是缓解恶性大肠梗阻的一种安全有效的治疗方法。